Monday 05 May 2025
Internal Reference Number: FOI_8426
Date Request Received: 05/02/2025 00:00:00
Date Request Replied To: 11/03/2025 00:00:00
This response was sent via: By Email
Request Summary: Biologic medicines in gastroenterology
Request Category: Researcher
| Question Number 1: How many patients were treated in the last 3 months by the Gastroenterology department (for any medical condition) with the following biologic drugs: • Adalimumab - Humira • Adalimumab Biosimilar • Etrasimod • Filgotinib • Golimumab • Infliximab - Remicade • Infliximab Biosimilar • Mirikizumab • Ozanimod • Risankizumab • Tofacitinib • Upadacitinib • Ustekinumab - Stelara • Ustekinumab Biosimilar • Vedolizumab | |
| Answer To Question 1: • Adalimumab - Humira 6 • Adalimumab Biosimilar 47 • Etrasimod 0 • Filgotinib 19 • Golimumab <5 • Infliximab - Remicade <5 • Infliximab Biosimilar 128 • Mirikizumab 6 • Ozanimod 0 • Risankizumab 5 • Tofacitinib <5 • Upadacitinib 25 • Ustekinumab - Stelara 6 • Ustekinumab Biosimilar 83 • Vedolizumab 55 | |
| Question Number 2: Could you please provide the numbers of patients treated for Crohn’s Disease in the last 3 months with the following biologic drugs: • Adalimumab - Humira • Adalimumab Biosimilars • Golimumab • Infliximab - Remicade • Infliximab Biosimilar • Risankizumab • Upadacitinib • Ustekinumab - Sterala • Ustekinumab Biosimilar • Vedolizumab | |
| Answer To Question 2: • Adalimumab - Humira 5 • Adalimumab Biosimilars 39 • Golimumab 0 • Infliximab - Remicade 0 • Infliximab Biosimilar 63 • Risankizumab 5 • Upadacitinib 15 • Ustekinumab - Sterala 5 • Ustekinumab Biosimilar 71 • Vedolizumab 25 | |
| To return to the list of all the FOI requests please click here |
Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.
